Fieldpoint Private Securities’s Amgen AMGN Stock Holding History

Fieldpoint Private Securities’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$126K	Sell	517 -1,918	-79%	-$470K	0.04%	321
2022 Q1	$589K	Sell	2,435 -587	-19%	-$135K	0.12%	183
2021 Q4	$680K	Sell	3,022 -526	-15%	-$111K	0.13%	174
2021 Q3	$754K	Sell	3,548 -17	-0.5%	-$3.91K	0.17%	142
2021 Q2	$813K	Sell	3,565 -823	-19%	-$202K	0.18%	139
2021 Q1	$1.09M	Buy	4,388 +537	+14%	+$128K	0.26%	102
2020 Q4	$885K	Sell	3,851 -255	-6%	-$58.8K	0.2%	128
2020 Q3	$1.04M	Buy	4,106 +397	+11%	+$98.4K	0.31%	97
2020 Q2	$875K	Buy	+3,709	New	+$846K	0.3%	100
2020 Q1	–	Sell	-198	Closed	-$48K	–	255
2019 Q4	$48K	Buy	198 +17	+9%	+$3.75K	0.01%	441
2019 Q3	$35K	Hold	181	–	–	0.01%	427
2019 Q2	$33K	Sell	181 -575	-76%	-$103K	0.01%	466
2019 Q1	$144K	Hold	756	–	–	0.06%	218
2018 Q4	$147K	Hold	756	–	–	0.07%	213
2018 Q3	$157K	Hold	756	–	–	0.06%	226
2018 Q2	$140K	Buy	756 +55	+8%	+$9.73K	0.05%	233
2018 Q1	$120K	Hold	701	–	–	0.05%	221
2017 Q4	$122K	Sell	701 -1,491	-68%	-$264K	0.06%	209
2017 Q3	$409K	Buy	2,192 +1,491	+213%	+$264K	0.18%	128
2017 Q2	$121K	Hold	701	–	–	0.08%	82
2017 Q1	$115K	Buy	+701	New	+$116K	0.09%	137

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fieldpoint Private Securities's AMGN Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Amgen (AMGN) stake by 79% in Q2 2022, selling an estimated $470K and leaving 517 shares worth $126K. The position accounts for 0.04% of the portfolio, ranked #321.

Fieldpoint Private Securities first reported a position in AMGN in Q1 2017 and has held it in 21 quarters since. The position peaked at $1.09M in Q1 2021. 2,353 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

Fieldpoint Private Securities held 517 shares of Amgen worth $126K as of Q2 2022.
Fieldpoint Private Securities sold 1,918 Amgen shares in Q2 2022, an estimated $470K.
Amgen made up 0.04% of Fieldpoint Private Securities's portfolio in Q2 2022, its #321 holding.
Fieldpoint Private Securities first reported a position in Amgen in Q1 2017 and has held it in 21 quarters since.
Fieldpoint Private Securities's Amgen position peaked at $1.09M in Q1 2021.
2,353 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.